Xi'an, China

Dan Yang

This inventor holds 24 USPTO granted patents and 1 published patent application, primarily in Antibacterial Compounds. Top assignees: Shaanxi University of Science and Technology, Xi'an Taikomed Pharmaceutical Technology Co., Ltd., Xi'an Kangyuansheng Biomedical Technology Co., Ltd.. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dan Yang. Retrieved from https://idiyas.com/inventor/dan-yang-3c9m0yzj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 50.0

Average Co-Inventor Count = 11.9

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Xi'an, CN (2019 - 2023)
  • Xi+3 an, CN (2022 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Areas of Expertise:
Antibacterial Activity
Pleuromutilin
Hydroxytyrosol
Seed Extract
Hepatoprotective
Cinnamic Acid
Antioxidant
Drug Resistance
Extraction Methods
Herbal Medicine
Antitumor Activities
24 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Dan Yang

Introduction

Dan Yang is a prominent inventor based in Xi'an, China, with an impressive portfolio of 24 patents to his name. His work is particularly focused on the field of antibiotic-resistant infections, demonstrating a commitment to improving healthcare through innovative solutions.

Latest Patents

Among Dan Yang's latest patents is a seed extract composition specifically designed for applications in antibiotic-resistant infections. This unique seed extract comprises several active components, including 0.4944-0.7142 mg/g of echinacoside, 6.624-7.617 mg/g of oleuropein, 0.4276-0.6309 mg/g of verbascoside, 3.927-4.684 mg/g of syringin, and 4.505-5.250 mg/g of forsythiaside B. The patent also details a method of preparing the seed extract and provides a composition for treating antibiotic-resistant infections using this extract.

Another significant innovation by Dan Yang is related to pleuromulin lipoic acid ester, which possesses antibacterial activity against drug-resistant bacteria. This invention includes a specific compound formula and a method for preparing this compound, underscoring his dedication to tackling resistant strains of bacteria.

Career Highlights

Dan Yang has been associated with esteemed institutions such as the Shaanxi University of Science and Technology. His work within academic and research environments has contributed significantly to his innovative pursuits.

Collaborations

Throughout his career, Dan Yang has collaborated with notable colleagues like Han Li and Bin Tian. These partnerships highlight the collaborative nature of innovation in the field of pharmaceuticals and biotechnology.

Conclusion

Dan Yang's contributions to the field of antibiotic resistance through his patents reflect a deep understanding of both science and the urgency of addressing modern healthcare challenges. His innovative work continues to inspire future advancements in medicine and biotechnology, positioning him as a key figure in the fight against antibiotic-resistant infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…